In non-small cell lung cancer, casticin and Coenzyme Q0 (CoQ0) suppress HIF-1α signaling, leading to reduced PKM2 expression, inhibition of glucose metabolism, and reversal of the Warburg effect (93, 94). The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.